About Novate
Novate is a company based in Galway (Ireland) founded in 2006 was acquired by BTG International in September 2018.. Novate has raised $17.97 million across 2 funding rounds from investors including Enterprise Ireland, BTG International and Omnes Capital. Novate operates in a competitive market with competitors including Pulmonx, Spiration, Neurent Medical, Gradient Denervation Technologies and Uptake Medical, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.97 M (USD)
in 2 rounds
-
Latest Funding Round
$12.42 M (USD), Series B
May 20, 2011
-
Investors
Enterprise Ireland
& 4 more
-
Employee Count
Employee Count
-
Acquired by
BTG International
(Sep 07, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
298 people
Leadership Team
132 people
Senior Team
105 people
Sales and Marketing
103 people
Product Management Team
65 people
Human Resources and Administration
40 people
Principal Team
37 people
Clinical Team
27 people
Unlock access to complete
Funding Insights of Novate
Novate has successfully raised a total of $17.97M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.42 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $12.4M
-
First Round
First Round
(19 Sep 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2011 | Amount | Series B - Novate | Valuation | Omnes Capital , Seroba Life Sciences | |
| Sep, 2007 | Amount | Series A - Novate | Valuation | Act Venture Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novate
Novate has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, BTG International and Omnes Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital funding is provided to innovative companies.
|
Founded Year | Domain | Location | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novate
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novate Comparisons
Competitors of Novate
Novate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Spiration, Neurent Medical, Gradient Denervation Technologies and Uptake Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of smart devices for treating pulmonary diseases
|
|
| domain | founded_year | HQ Location |
IntraBronchial Valve to treat lung disease
|
|
| domain | founded_year | HQ Location |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| domain | founded_year | HQ Location |
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
|
| domain | founded_year | HQ Location |
Endobronchial valves for emphysema treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Novate
When was Novate founded?
Novate was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Novate located?
Novate is headquartered in Galway, Ireland.
Is Novate a funded company?
Novate is a funded company, having raised a total of $17.97M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.55M, raised on Sep 19, 2007.
What does Novate do?
Novate Medical was founded in 2006 in Galway, Ireland, and operates in the medical device sector. Focus is placed on inferior vena cava filters for pulmonary embolism prevention in high-risk patients. The lead product, Sentry, is a bio-convertible filter that provides protection during the high-risk period and bioconverts to an unobstructed lumen after at least 60 days. Enrollment in its FDA trial has been completed in the US and Europe.
Who are the top competitors of Novate?
Novate's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.
Who are Novate's investors?
Novate has 5 investors. Key investors include Enterprise Ireland, BTG International, Omnes Capital, Seroba Lifesciences, and Act Venture Capital.